Tumour Immunology and Anti-Cancer Immunotherapy Unit France

Research

Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Tumour Immunology and Anti-Cancer Immunotherapy Unit published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Tumour Immunology and Anti-Cancer Immunotherapy Unit
Count Share
10 0.31

Outputs by subject (Share)

Outputs by subject
Subject Count Share
10 0.31

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.66 0.30 0.46 0.23 0.38

Compare Tumour Immunology and Anti-Cancer Immunotherapy Unit with other institutions

Collaboration

Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 53.82% Domestic
  • 46.18% International

Hover over the graph to view the percentage of collaboration.


Top 10 domestic collaborators with Tumour Immunology and Anti-Cancer Immunotherapy Unit by Share (108 total)

  1. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Institute Gustave-Roussy (IGR) (1.34)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.44
    Institute Gustave-Roussy (IGR)0.91
  2. Tumour Immunology and Anti-Cancer Immunotherapy Unit and National Institute for Health and Medical Research (INSERM) (1.10)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.44
    National Institute for Health and Medical Research (INSERM)0.66
  3. Tumour Immunology and Anti-Cancer Immunotherapy Unit and University of Paris-Sud (UPSud) (0.62)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.44
    University of Paris-Sud (UPSud)0.18
  4. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Ligue Contre Le Cancer (0.52)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.26
    Ligue Contre Le Cancer0.27
  5. Tumour Immunology and Anti-Cancer Immunotherapy Unit and University of Paris (0.48)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.20
    University of Paris0.28
  6. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Curie Institute (0.47)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.24
    Curie Institute0.24
  7. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Immunity and Cancer Unit (0.47)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.07
    Immunity and Cancer Unit0.39
  8. Tumour Immunology and Anti-Cancer Immunotherapy Unit and French National Centre for Scientific Research (CNRS) (0.42)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.31
    French National Centre for Scientific Research (CNRS)0.11
  9. Tumour Immunology and Anti-Cancer Immunotherapy Unit and University of Paris-Saclay (0.41)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.23
    University of Paris-Saclay0.18
  10. Tumour Immunology and Anti-Cancer Immunotherapy Unit and SIRIC ILIAD (0.38)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.04
    SIRIC ILIAD0.34

Top 10 international collaborators with Tumour Immunology and Anti-Cancer Immunotherapy Unit by Share (109 total)

  1. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Agency for Science, Technology and Research (A*STAR) (1.65)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.23
    Agency for Science, Technology and Research (A*STAR)1.43
  2. Tumour Immunology and Anti-Cancer Immunotherapy Unit and National University of Singapore (NUS) (0.81)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.17
    National University of Singapore (NUS)0.64
  3. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Duke-NUS Medical School (0.78)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.17
    Duke-NUS Medical School0.61
  4. Tumour Immunology and Anti-Cancer Immunotherapy Unit and The University of Texas MD Anderson Cancer Center (0.67)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.04
    The University of Texas MD Anderson Cancer Center0.63
  5. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Singapore Health Services Pte. Ltd. (SingHealth) (0.61)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.17
    Singapore Health Services Pte. Ltd. (SingHealth)0.44
  6. Tumour Immunology and Anti-Cancer Immunotherapy Unit and University of Zurich (UZH) (0.49)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.02
    University of Zurich (UZH)0.48
  7. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Duke University (0.47)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.17
    Duke University0.31
  8. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Ludwig Maximilians University of Munich (LMU) (0.40)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.02
    Ludwig Maximilians University of Munich (LMU)0.38
  9. Tumour Immunology and Anti-Cancer Immunotherapy Unit and National University Health System (NUHS) (0.38)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.04
    National University Health System (NUHS)0.34
  10. Tumour Immunology and Anti-Cancer Immunotherapy Unit and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) (0.35)
    Tumour Immunology and Anti-Cancer Immunotherapy Unit0.13
    Scientific Institute for Research, Hospitalization and Healthcare (IRCCS)0.21

Relationships

Partner Institutions

Tumour Immunology and Anti-Cancer Immunotherapy Unit is a research collaboration whose article contributions are accrued to its participating partner institutions below.